Soligenix, Inc.
corporate_fare Company Profile
Soligenix, Inc. (NASDAQ:SNGX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for SNGX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-21, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 17 rated 8 or above. Recent SEC coverage for SNGX spans 8-K, 424B3, 10-Q, PRER14A.
Recent high-impact activity:
- Soligenix Stockholders Approve Reverse Split and 67% Increase in Authorized Shares
- Soligenix Registers 5.3M Warrant Shares as Going Concern and Nasdaq Delisting Risks Mount
- Soligenix Q2 2026: Going Concern Warning, Nasdaq Delisting Risk, and Heavy ATM Dilution
- Soligenix Q2 10-Q Flags Going Concern, Nasdaq Delisting Risk, and Heavy ATM Dilution
- Soligenix Q2 2026: Going Concern, Nasdaq Delisting Risk, and Massive ATM Dilution
Financial Snapshot
Short Interest & Short Volume
1.58 days to coverFINRA reported short interest of 202,558 shares in SNGX as of the September 15, 2026 settlement, a 3.8% decrease from the prior period — about 1.6 days to cover at its recent average daily volume. On October 2, 2026, 2.3% of SNGX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for SNGX, detected from its recent SEC filings · based on capital-structure filings through 2026-08-07.
Going Concern Warning · Nasdaq Delisting Risk
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →